PeptiMed, Inc.
PeptiMed, Inc. is a Madison, Wisconsin-based biotechnology company that develops therapeutic drugs targeting the EVI1 gene for the treatment of skin, breast, lung, prostate, and ovarian cancers.
Currently, there are no issues on this topic.
Find more companies like PeptiMed, Inc.
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.